6.16

3.30% -0.21

After Hours: 6.11 -0.05 -0.81%

Cumberland Pharmaceuticals Inc (CPIX)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Cumberland Pharmaceuticals Inc stock is traded at $6.16, with a volume of 46,836. It is down -3.30% in the last 24 hours and up +6.21% over the past month. Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment, which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The firm promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. Its brands include Acetadote, Caldolor, Kristalose, Sancuso, Vaprisol, and Vibativ. Geographically, the company generates revenue from China, South Korea, Russia, Mexico, Australia, and Saudi Arabia.

Previous Close:

$6.37

Open:

$6.3

24h Volume:

46,836

Relative Volume:

0.05

Market Cap:

$92.30M

Revenue:

$41.94M

Net Income/Loss:

$-7.40M

P/E Ratio:

-12.48

EPS:

-0.4935

Net Cash Flow:

$1.29M

1W Performance:

-9.94%

1M Performance:

+6.21%

6M Performance:

+30.51%

1Y Performance:

+95.56%

1-Day Range:

$6.04

$6.75

1-Week Range:

$6.04

$7.355

52-Week Range:

$1.85

$7.355

Cumberland Pharmaceuticals Inc Stock (CPIX) Company Profile

Name

Cumberland Pharmaceuticals Inc

Sector

Healthcare (1100)

Industry

Drug Manufacturers - Specialty & Generic (86)

Phone

615-255-0068

Address

1600 WEST END AVENUE, NASHVILLE,, TN

Employee

Twitter

Next Earnings Date

2026-08-04

Latest SEC Filings

CPIX's Discussions on Twitter

Compare CPIX vs TAK, HLN, TEVA, ZTS, UTHR

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CPIX Cumberland Pharmaceuticals Inc	6.16	97.09M	41.94M	-7.40M	1.29M	-0.4935
TAK Takeda Pharmaceutical Co Adr	16.89	50.65B	29.91B	1.30B	3.49B	0.4056
HLN Haleon Plc Adr	9.72	41.09B	14.54B	2.22B	2.58B	0.4871
TEVA Teva Pharmaceutical Industries Ltd Adr	35.29	39.45B	17.53B	1.58B	444.18M	1.3457
ZTS Zoetis Inc	75.42	30.13B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	547.25	23.00B	3.17B	1.29B	1.01B	27.09

Cumberland Pharmaceuticals Inc Stock (CPIX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-12-12	Reiterated	UBS	Neutral
Feb-01-11	Reiterated	UBS	Neutral
Dec-16-10	Downgrade	UBS	Buy → Neutral
Aug-17-10	Downgrade	Jefferies	Buy → Hold
Aug-17-10	Reiterated	Morgan Joseph	Buy
Aug-17-10	Reiterated	UBS	Buy
May-14-10	Reiterated	Morgan Joseph	Buy

View All

Cumberland Pharmaceuticals Inc Stock (CPIX) Latest News

Jul 01, 2026

Cumberland Pharmaceuticals Sells Branded Drug Portfolio to Apotex for $100M, Refocuses on Rare Disease Pipeline 1 - Minichart

Jul 01, 2026

CPIXCumberland Pharmaceuticals Inc Latest SEC Filings - Finviz

Jul 01, 2026

Cumberland Refocuses on Rare Disease Pipeline After Asset Sale - TipRanks

Jul 01, 2026

Cumberland (CPIX) nets $100M from Apotex deal, shifts to rare disease pipeline - Stock Titan

Jul 01, 2026

Cumberland Pharmaceuticals closes $100 million sale of drug portfolio - The Business Journals

Jul 01, 2026

Cumberland sells branded drug portfolio to Apotex for $100m - Investing.com

Jul 01, 2026

Cumberland sells branded U.S. drugs to Apotex for $100M - Stock Titan

Jul 01, 2026

Jun 27, 2026

Cumberland Pharma advances Duchenne program with new safety, efficacy data - MSN

Jun 27, 2026

Cumberland Pharma Advances Duchenne Program With New Safety, Efficacy Data - Sahm

Jun 27, 2026

Jun 26, 2026

Cumberland shares updated trial results for DMD heart therapy - Investing.com UK

Jun 26, 2026

Why Is Cumberland Pharma Stock Gaining Friday?Cumberland Pharma (NASDAQ:CPIX) - Benzinga

Jun 26, 2026

Cumberland says updated DMD heart data strengthen ifetroban case - Stock Titan

Jun 26, 2026

Jun 25, 2026